Dhunseri Investments Ltd presents a clean standalone face, zero borrowings, unqualified audit opinions, and a 74.95% promoter holding with no pledge, but the consolidated picture is materially different. The group carries ₹951 crore of debt, all in subsidiaries, and has generated operating cash flow covering only one-third of adjusted profit over a decade. Two consecutive years of qualified consolidated audit opinions and a failed shareholder vote on a ₹22.5 crore related-party loan point to control weaknesses that sit beneath the holding-company structure.
Key findings
- All ₹951 crore of consolidated debt sits in subsidiaries, with no parent borrowings
Major- Dhunseri Investments Ltd standalone had no borrowings in FY2025-26 or FY2024-25. Consolidated borrowings totalled ₹951 crore, all residing in subsidiaries. Subsidiary assets of ₹560.22 crore are pledged as security, and fixed deposits of ₹50.78 crore are under lien, creating material off-balance-sheet exposure for the listed parent. - The consolidated audit was qualified for two years over a subsidiary's potential unregistered NBFC status, and FY26 flags audit-trail deficiencies
Major- The consolidated audit opinion was qualified in FY2022 and FY2023 because a subsidiary's income from financial assets and financial assets each exceeded 50% of the respective totals, raising a view that it met the RBI principal-business test for NBFC registration from 1 April 2022. The FY2026 consolidated audit report states that a subsidiary's accounting software had a configurable audit-trail feature, a single user ID, and was operated by a third-party service provider, preventing the auditor from commenting on whether the feature was enabled at the database level. - A subsidiary advanced a ₹22.5 crore loan to a director-interested entity without shareholder approval, and the ratifying resolution failed
Major- During FY2025, a subsidiary advanced a loan of ₹22.5 crore to a company in which its directors were interested without passing a special resolution under Section 185 of the Companies Act, 2013. The special resolution sought at the subsidiary's AGM on 20 August 2024 failed because votes in favour were less than three times votes against; the entire loan plus interest was received back on 30 August 2024. - Investments in subsidiaries and associates are a recurring Key Audit Matter, yet no impairment has been recognised
Major- In FY26, total investments in subsidiaries and associates stood at ₹303.73 crore, representing 63% of the company's total investments, and their impairment assessment was a Key Audit Matter in the standalone audit report. This has been a Key Audit Matter every year from FY22 through FY26, with the carrying amount ranging from ₹241.44 crore to ₹303.73 crore. In FY26 consolidated, a diminution of ₹35.45 crore was recognised in a subsidiary's financials, yet no impairment loss has been recognised on the standalone investments across the review period. - A ₹269 crore inter-promoter portfolio swap was executed with each leg valued at over 400% of the counterparty's turnover
Minor- In FY2025, Dhunseri Investments Ltd purchased 8.79% of Dhunseri Ventures Ltd from Naga Dhunseri Group Ltd for an estimated ₹142.15 crore and sold 45.77% of Dhunseri Tea & Industries Ltd to NDGL for an estimated ₹126.73 crore, with both transactions approved by shareholders via postal ballot on 10 January 2025. The purchase was valued at approximately 489% of NDGL's audited consolidated turnover of ₹29.07 crore, and the sale at approximately 434%. - Promoter family dominates the board, with MD remuneration revised upward and a former director immediately retained as paid advisor
Minor- Promoter and promoter group shareholding remained at 74.95% from FY21 through FY26. Mrs. Aruna Dhanuka, wife of the Chairman, serves as Managing Director & CEO, and her remuneration was revised upward effective 1 January 2024 to a salary of ₹2,50,000 per month plus perquisites. Mr. Mrigank Dhanuka, son of the Chairman and MD, resigned as Non-Executive Non-Independent Director on 12 February 2025 and was immediately appointed as Advisor to the Board at ₹2,00,000 per month.
What to watch
- MD re-appointment and Independent Director appointment. Re-appointment of Mrs. Aruna Dhanuka as Managing Director & CEO for five years from 27 May 2026, and appointment of Mrs. Rusha Mitra as Independent Director, to be voted on at the 29th AGM on 20 August 2026.
- IT-complex CWIP resolution. Completion or de-notification of the suspended IT-complex CWIP (₹46.23 crore) as the Group evaluates alternatives including de-notification, per the FY26 annual report.
- Impairment on subsidiary and associate investments. Next annual audit report for FY2026-27 to disclose whether any impairment has been recognised on the ₹303.73 crore standalone investments in subsidiaries and associates or the consolidated equity-accounted investees.
- BOPP Project borrowings ramp-up. Next annual report to disclose whether the BOPP Project, Kathua borrowings (₹264.99 crore from Oldenburgische Landesbank AG and ₹291.62 crore from SBI) continue to ramp up, with final maturities in 2036 and 2039.
- Audit-trail deficiencies in subsidiary software. The FY2026 audit-trail deficiencies in the subsidiary's accounting software, configurable edit-log, single user ID, third-party service provider, the independent auditor was unable to comment on whether the audit-trail feature was enabled throughout the year or at the database level as of the FY2025-26 audit report date.
Bottom line: This is a holding company whose standalone record is clean but whose consolidated reality carries debt, weak cash conversion, and control qualifications that the parent-level audit does not capture. The risk is structural: subsidiary obligations sit off the parent's balance sheet, subsidiary governance lapses have required audit qualifications and a failed shareholder vote, and a decade of thin operating cash flow has been supplemented by other income while dividends continued. Watch the BOPP project debt ramp, the fate of the suspended IT park, and whether the next audit report addresses impairment on the subsidiary investments that dominate the balance sheet.